Comparison of two contouring guidelines for radiation therapy in post mastectomy patients with breast cancers

Comparison of RTOG and ESTRO contouring guidelines in post mastectomy patients with breast cancer - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/065163

Enrollment

Registered

2024-04-03

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site

Interventions

Intervention1: Radiation therapy: Radiation therapy in post mastectomy breast cancer with two different guidelines and comparing the outcome Radiation dose- 26 Gy in 5 fractions once daily for 5 days

Eligibility

Inclusion criteria

Inclusion criteria: 1.Early stage 2.Post Mastectomy 3.Irrespective of Chemotherapy 4.Irrespective of Hormone status 5.Irrespective of the focality

Exclusion criteria

Exclusion criteria: 1.Refusal to consent 2.Patients with breast conservation surgery 3.Late stage/ Metastatic

Design outcomes

Primary

Measure	Time frame
To compare the two contouring guidelines in terms of coverage of tumour volumes , nodal volumes and sparing of normal organs at risks and to look for acute toxicities at 4-6 weeks after treatmentTimepoint: 1 month	—

Secondary

Measure	Time frame
To assess for acute toxicities after radiation therapyTimepoint: 1 Month	—

Countries

India

Contacts

Public ContactBiswajit Nath

Postgraduate institute of medical education and research , Chandigarh

drbudhi@gmail.com9815981176

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026